Anterix (ATEX) Current Deferred Revenue (2014 - 2026)

Anterix's Current Deferred Revenue history runs 13 years deep, the most recent figure standing at $161.2 million for Q1 2026.

• Quarterly Current Deferred Revenue rose 29.28% year-over-year to $161.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.2 million (up 29.28% YoY) and the FY2026 annual result came in at $161.2 million, up 29.28% from the prior year.
• Current Deferred Revenue was $161.2 million for Q1 2026 at Anterix, up from $7.9 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $161.2 million in Q1 2026 and bottomed at $6.0 million in Q4 2024.
• A 5-year average of $76.9 million and a median of $60.8 million in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 7273.54% — and 2023, when it fell 13.75%.
• Anterix's Current Deferred Revenue stood at $8.0 million in 2022, then dropped by 13.75% to $6.9 million in 2023, then dropped by 13.59% to $6.0 million in 2024, then soared by 31.95% to $7.9 million in 2025, then soared by 1948.79% to $161.2 million in 2026.
• Business Quant data shows ATEX's Current Deferred Revenue at $161.2 million in Q1 2026, $7.9 million in Q4 2025, and $130.4 million in Q3 2025.